ABPWW OTC
Abpro Holdings Inc
1W: -12.2%
1M: -17.9%
3M: -61.4%
YTD: -42.5%
$0.00
Last traded 2026-02-19 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.6M
52W Range0.002-0.0194
Volume2,004
Avg Volume24,518
Beta0.15
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJin Wook Suk
Employees6
SectorHealthcare
IndustryBiotechnology
IPO Date2022-03-09
Websiteabpro.com
68 Cummings Park Drive
Woburn, MA 01801
US
Woburn, MA 01801
US
617 225 0808
About Abpro Holdings Inc
Abpro Holdings, Inc., a biotechnology company, engages in developing antibody therapeutics for patients with immuno-oncology, ophthalmology, and autoimmunity issues. Its platform DiversImmune addresses a bottleneck in the antibody therapeutics industry. Its lead product candidates include ABP-100 for the treatment of breast, gastric, and colorectal cancers; and ABP-201 for the treatment of vascular diseases of the eye. The company has a strategic partnership with Abpro Bio Co. Ltd and NJCTTQ. The company was formerly known as Abpro Corporation and changed its name to Abpro Holdings, Inc. in November 2024. Abpro Holdings, Inc. was incorporated in 2004 and is headquartered in Woburn, Massachusetts.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Suk Jin Wook (Miles) | P-Purchase | 72,035 | $0.28 | 2025-07-31 |
| Lee Soo Young | A-Award | 60,600 | $0.32 | 2025-07-25 |
| Eisenberg Anthony D. | A-Award | 60,600 | $0.32 | 2025-07-25 |
| Suk Jin Wook (Miles) | A-Award | 500,000 | — | 2025-07-25 |
| Suk Jin Wook (Miles) | P-Purchase | 16,200 | $0.26 | 2025-05-19 |